Navigation Links
Resverlogix desincorpora RVX Therapeutics Inc. para sus accionistas
Date:4/8/2013

ting dates are anticipated to be on or around April 25, 2013 and May 28, 2013, respectively. A management information circular containing a complete description of the Arrangement and a description of tax implications to shareholders will be sent to shareholders of Resverlogix in connection with the special meeting to approve the Arrangement.

No se podrá asegurar o garantizar que la desincorporación se lleve a cabo.

Resverlogix celebrará una rueda de prensa en directo y emisión web con preguntas y respuestas a las 11 a.m. MDT del 8 de abril de 2013.

Enlace a la emisión web:

http://services.choruscall.ca/links/resverlogix130408.html

Números de llamada de la rueda de prensa:

Canadá y Estados Unidos, número gratuito: 1-800-319-4610

Fuera de Canadá y Estados Unidos llame al número: +1-604-638-5340

Acerca de Resverlogix Corp.

Resverlogix Corp. (TSX:RVX) es una compañía cardiovascular en fase clínica con una tecnología de plataforma epigenética que modula la producción de proteína. Resverlogix está desarrollando RVX-208, una molécula pequeña de primera clase para el tratamiento de la ateroesclerosis. RVX-208 es el primer inhibidor de bromodominio BET en ensayos clínicos. Los nuevos compuestos que surgen de la plataforma de descubrimiento de fármaco epigenético de Resverlogix funcionan por medio de la inhibición de los bromodominios BET, y cuentan con el potencial para impactar en múltiples enfermedades, incluyendo el cáncer, enfermedades neurodegenerativas y diabetes mellitus. Las acciones ordinarias de Resverlogix Corp. cotizan en la Bolsa de Valores de Toronto (TSX: RVX). Si desea más información visite la página web http://www.res
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Galectin Therapeutics: Turning Atlanta into Americas Next Silicon Valley
2. Galectin Therapeutics Reports Full Year and Fourth Quarter 2012 Financial Results
3. Aratana Therapeutics Adds To Drug Development Team
4. Biovista und DART Therapeutics nehmen Zusammenarbeit auf, um auf Duchenne-Muskeldystrophie abzielende Medikamente neu zu positionieren
5. Novira Therapeutics Completes $25 Million Series A Financing
6. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
7. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
8. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
9. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
10. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
11. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 28, 2014 PrimeSource Building ... materials, selected SoundConnect to support their ... based audio and web conferencing platform GlobalMeet powered ... PrimeSource’s employees’ needs. SoundConnect delivers award winning ... PrimeSource Building Products will be utilizing GlobalMeet ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Varian Medical ... expand its current Salt Lake City manufacturing facility and ... of Utah to ultimately create 1,000 new full time ... , “Utah is home to hardworking people with ... be credited with Varian’s success in the manufacturing of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 In ... through Lawrence Livermore National Security LLC ... develop and deliver a state-of-the-art laser system for ... (ELI Beamlines), under construction in the Czech Republic. ... the laser system, called the " High repetition-rate ...
(Date:8/27/2014)... of nature,s mysteries is how plants survive impact ... the sun,s rays, while using this energy for ... in the plant,s blades quickly dissipate the energy ... quakes. Researchers at DTU Physics have now managed ... algae and bacteria contain light-absorbing proteins which play ...
Breaking Biology Technology:PrimeSource Chooses SoundConnect as Collaboration Provider 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3DTU researchers film protein quake for the first time 2
... right size and existing in the limbo between a solid ... improving the efficiency of chemical catalysts that can create better ... in this transitional state, a catalyst can achieve its utmost ... temperature, according to a pair of Duke University researchers. A ...
... At the heart of the method is a so-called ... channel in a semiconductor circuit. The scientists created a ... of electrons in the semiconductor. The key is that ... the channel, making possible extremely high-precision measurements of the ...
... Transgenomic, Inc. (OTC Bulletin Board: TBIO ... the company as Medical Director for Laboratory Services.  In ... for leading the strategic vision and managing the day-to-day ... Dr. Johnson brings to Transgenomic nearly 20 years ...
Cached Biology Technology:Smaller is better in the viscous zone 2Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services 2Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services 3Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services 4
(Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) ... the Genetics Society of America,s 27th Annual Mouse ... 3, 2014 in Pacific Grove, California. These ... students, post doctorates and scientists from underrepresented groups ... and to encourage the participation of young scientists ...
(Date:8/28/2014)... that could positively impact the global battle ... thanks to researchers in Penn State,s College ... made from the seaweed-derived food ingredient carrageenan ... provides a woman-initiated, drug-delivery vehicle that can ... infections during unprotected heterosexual intercourse, the researchers ...
(Date:8/28/2014)... the most commonly diagnosed learning disability in the ... occurs when the regions of the brain that ... use of non-invasive functional neuroimaging tools has helped ... However, most prior work has focused on only ... gap in our understanding of how multiple brain ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Dyslexic readers have disrupted network connections in the brain 2
... caught male topi antelopes in the act of faking fear in ... chances of having sex. The male antelopes, observed in southwest ... when females in heat are in their territories. When the females ... for some males to fit in a quick mating opportunity. ...
... , May 24 BIO-key International, Inc. (OTC Bulletin ... that Evidian has integrated BIO-key,s biometric software into its Enterprise Single ... solution at two major pharmaceutical companies. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) , ...
... Neurone Disease Association is funding its first ever stem ... this fatal, neurological condition. Pulling together world-class ... Prof Sir Ian Wilmut from the University of Edinburgh; ... Tom Maniatis of Columbia University New York; the Association,s ...
Cached Biology News:Male antelopes trick females into extra sex opportunities 2Male antelopes trick females into extra sex opportunities 3BIO-key(R) Biometric Identification Now Incorporated Into Evidian Enterprise Single Sign-On Solution 2BIO-key(R) Biometric Identification Now Incorporated Into Evidian Enterprise Single Sign-On Solution 3BIO-key(R) Biometric Identification Now Incorporated Into Evidian Enterprise Single Sign-On Solution 4Harnessing the power of stem cells to unlock the secrets of motor neuron disease 2Harnessing the power of stem cells to unlock the secrets of motor neuron disease 3Harnessing the power of stem cells to unlock the secrets of motor neuron disease 4
...
Human sIL-2R/CD25 ELI-PAIR Kit...
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Lipid Phosphate Phosphohydrolase 2...
Biology Products: